US health advisers urged regulators to approve Truvada, made byGilead Sciences, as the first preventive pill against HIV/AIDS instead of just a treatment for infected people. The favorable vote came after clinical trials showed Truvada could lower the risk of HIV in gay men by 44 to 73 percent, and was hailed by some…
HONG KONG  More than 90 percent of gay men in the Asia Pacific region don’t have access to HIV prevention and care services, as levels of the disease soar to “alarming levels”, a UN report said Monday. The study, conducted by the United Nations Development Programme (UNDP), said discriminatory…